Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-300
Closed -$4K 10478
2014
Q2
$4K Buy
300
+140
+88% +$2.13K ﹤0.01% 9656
2014
Q1
$3K Sell
160
-2,060
-93% -$42.8K ﹤0.01% 9834
2013
Q4
$42K Sell
2,220
-10,980
-83% -$151K ﹤0.01% 7180
2013
Q3
$175K Buy
13,200
+1,560
+13% +$19.6K ﹤0.01% 5347
2013
Q2
$103K Buy
+11,640
New +$115K ﹤0.01% 5870

Other funds holding FRO

UBS's FRO Position: Q3 2014 in Review

UBS reduced its Frontline (FRO) stake by 88% in Q3 2014, selling an estimated $208K and leaving 2,718 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #8192.

UBS first reported a position in FRO in Q2 2013 and has held it in 6 quarters since. The position peaked at $1.26M in Q1 2014. 83 funds tracked by Wall St. Rank hold FRO as of Q3 2014.

  • UBS held 2,718 shares of Frontline worth $17K as of Q3 2014.
  • UBS sold 19,038 Frontline shares in Q3 2014, an estimated $208K.
  • Frontline made up ﹤0.01% of UBS's portfolio in Q3 2014, its #8192 holding.
  • UBS first reported a position in Frontline in Q2 2013 and has held it in 6 quarters since.
  • UBS's Frontline position peaked at $1.26M in Q1 2014.
  • 83 funds tracked by Wall St. Rank held Frontline as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.